Several aspects of equine ovarian physiology are unique among domestic species. Moreover, follicular growth patterns are very similar between horses and humans. This study aimed to characterize, for the first time, global gene expression profiles associated with growth and preovulatory (PO) maturation of equine dominant follicles. Granulosa cells (GCs) and theca interna cells (TCs) were harvested from follicles (n ¼ 5) at different stages of an ovulatory wave in mares corresponding to early dominance (ED; diameter !22 mm), late dominance (LD; !33 mm) and PO stage (34 h after administration of crude equine gonadotropins at LD stage), and separately analyzed on a horse gene expression microarray, followed by validation using quantitative PCR and immunoblotting/immunohistochemistry. Numbers of differentially expressed transcripts (DETs; !2-fold; P , 0.05) during the ED-LD and LD-PO transitions were 546 and 2419 in GCs and 5 and 582 in TCs. The most prominent change in GCs was the down-regulation of transcripts associated with cell division during both ED-LD and LD-PO. In addition, DET sets during LD-PO in GCs were enriched for genes involved in cell communication/adhesion, antioxidation/detoxification, immunity/inflammation, and cholesterol biosynthesis. In contrast, the largest change in TCs during the LD-PO transition was an upregulation of genes involved in immune activation, with other DET sets mapping to GPCR/cAMP signaling, lipid/amino acid metabolism, and cell proliferation/survival and differentiation.
INTRODUCTION
In monovular species, including humans, horses, and cattle, waves of follicular growth develop in succession during a female's reproductive life. All follicles of a wave initially grow at a similar rate. Once a follicle (usually the largest) reaches a critical size (about 22 mm in the horse), a phenomenon known as diameter deviation begins, whereby this follicle (occasionally two or three follicles) continues its growth as dominant follicle whereas all other follicles (subordinate follicles) cease growth and undergo atresia [1] . Subsequent maturation of the dominant follicle may be followed, if a luteinizing hormone (LH) surge occurs a few days later, by ovulation and transformation of the follicle remnants into a corpus luteum. The growth and maturation of a dominant follicle and subsequent follicle-luteal transition involve sequential and profound changes in tissue structure and function requiring finely tuned and coordinated changes in gene expression at each developmental step. Hundreds of genes involved in follicle selection (i.e., differentially expressed between early dominant [ED] and subordinate follicles) or in ovulation and the associated follicle-luteal transition have been identified by transcriptome profiling of ruminant [2] [3] [4] [5] [6] , pig [7, 8] , and primate [9, 10] tissues, often using either whole follicles or granulosa cells (GCs). Comparatively more limited information exists in relation to the development of the dominant follicle between the time of selection and the preovulatory (PO) period, particularly in relation to each separate follicular wall cell component, i.e., GCs and theca cells (TCs).
Several distinct features characterize follicular development in the horse among domestic species [reviewed in 11] ; these include the growth of a relatively small number of waves (one or two) during an estrous cycle, a gradual and protracted increase in circulating LH associated with the growth of the dominant follicle (in contrast with a sharp and short-lived PO LH surge in other species), a very large diameter attained by the PO follicle (two to three times that of cattle follicles), a relatively long (39-42 h ) ovulatory process, and the spatial restriction of follicular rupture to a fixed area of the ovary called the ovulatory fossa. Together with these unique features, deficient follicular growth and ovulatory failure are relatively common in breeding horses, and constitute an important cause of low reproductive efficiency and economic loss by the equine industry worldwide [11] . Yet the mechanisms of follicle development in the horse are still poorly understood and, unlike in other domestic species, genome-wide identification of genes involved in follicle development has not been performed. Moreover, follicular growth and associated hormonal patterns in the horse have been likened to those in humans [12] , and the horse has been proposed as a model to study follicular maturation, anovulation (for example development of luteinized unruptured follicles, which is relatively prevalent in both humans and horses), and ovarian aging [13] [14] [15] . Importantly, the large diameter of follicles in the horse together with their relatively long developmental timelines provide a unique opportunity to experimentally target, in a relatively easy and noninvasive manner, follicle stages in vivo that are not accessible in any other large animal model including cattle [16, 17] . Thus, much benefit could be gained from a better understanding of follicle development in the mare, particularly given that access to human follicular tissues for analysis is often limited to luteinized GCs.
The above considerations together with recent progress in the annotation of the horse genome provide a unique opportunity, using the equine model, to more comprehensively investigate the molecular signatures physiologically associated with follicle development. With this in mind, in the present study transcriptome analyses were performed of equine GCs and TCs to identify genes distinctly involved in the growth and PO maturation of dominant follicles.
MATERIALS AND METHODS

Experimental Groups and Procedures
Fifteen mature, cycling Welsh pony mares were kept indoors at INRA (Nouzilly, France). They were fed concentrates and had free access to water and trace-mineralized salt. Transrectal ultrasonography was used daily during the second half of their ovulatory cycles to monitor the development of ovulatory follicular waves. At a predetermined stage during a wave (see below), the ovary with the presumptive ovulatory follicle was removed via colpotomy using a chain ecraseur, as described [18] . Before ovariectomy, the animals were placed in stocks and sedated with Domosedan (10 lg/kg i.v.; Pfizer). Propantheline bromide (60 mg/100 kg i.v.; Sigma) was administered to facilitate transrectal manipulation. All animal procedures were approved by the French Agricultural and Veterinary Research Agencies (C37-175-2/37-035) and conducted in accordance with the guidelines for Care and Use of Agricultural Animals in Agricultural Research and Teaching.
Mares were randomly assigned to each of three groups (n ¼ 5 mares/group) according to which ovaries were collected during an ovulatory wave 1) once the largest growing follicle reached 22.0 mm in diameter, corresponding to the ED phase; 2) once the follicle reached 33.0 mm, corresponding to the late dominant (LD) phase and before the expected beginning of an endogenous ovulationinducing increase in circulating LH [19] ; or 3) at the PO phase, 34 h after an i.v. injection of an ovulatory dose of crude equine gonadotropins (CEG; 15 mg i.v. [20] ) given when the largest follicle reached 33 mm.
Collection of Tissue Samples
After ovarian collection, the target follicle was dissected from the surrounding tissue with a scalpel, and follicular fluid was aspirated, centrifuged, and stored at À808C. Under a dissecting microscope, the follicle was cut into several pieces and the theca externa and other surrounding tissues were dissected away from the theca interna using fine forceps. The theca interna was then gently scraped with a bent glass Pasteur pipette to release the attached GCs. TC and GC fractions were separately snap frozen in liquid nitrogen and stored until extraction of RNA or were placed in lysis buffer (10 mM Tris-HCl, 10 mM KCl, 0.5 mM EDTA, protease inhibitor cocktail; Sigma) and disrupted with a pellet pestle followed by sonication for 10 min and storage at À208C until Western blotting. In addition, pieces of intact follicular wall were placed in Bouin buffer for 6 h and then stored in 70% ethanol for later use in immunohistochemistry. RNA from the pituitaries of two healthy horses (used as positive control for quantitative PCR (qPCR) of gonadotropin subunits; see below) was kindly provided by Dr. J.A. Keen (School of Veterinary Studies, The University of Edinburgh).
Microarray Analyses
Total RNA was extracted using TRIzol (Life Technologies Ltd.) and was analyzed with the Agilent Bioanalyzer 2100 (Agilent Technologies U.K. Ltd.). Levels of BMP7, a gene expressed in TCs but not in GCs [21] , and FSHR were determined in all samples by qPCR (see below) to confirm the absence of crosscontamination of samples collected from the same follicle.
RNA with an integrity value .7.0 was amplified using the MessageAmp II amplified RNA (aRNA) Amplification Kit (Life Technologies), following the manufacturer's instructions, after being spiked in with control RNAs (Agilent Technologies). In brief, RNA (500 ng) was reverse transcribed with a T7 oligo d(T) primer followed by second strand synthesis. The double-stranded cDNA was purified on a spin column followed by in vitro transcription and further purification of the resulting aRNA. The yield and quality of the aRNA were assessed using a NanoDrop TM spectrophotometer (Labtech International Ltd.) and a RNA 6000 nanochip on the Agilent Bioanalyzer. Cy3 dye (Agilent Technologies) was coupled to aminoallyl uridine triphosphate in the amplified aRNA, and the yield and specific activity of the eluate containing the purified labeling reactions was quantified using Nanodrop. After incubation with fragmentation buffer at 608C for 30 min, Cy3-labeled aRNA was loaded to the Agilent Horse Gene Expression Microarray (version 2010; Agilent Technologies) and the slides were placed in rotisserie in a hybridization oven at 658C for 17 h. GC and TC samples were separately hybridized, and within each cell type samples were distributed so that all experimental groups were evenly represented in each slide. The horse microarray was composed of 43 603 probes representing 24 417 transcripts coding for 15 485 known or predicted gene products. All samples were analyzed simultaneously using the same batch of arrays.
After hybridization, slides were washed and scanned on a 4200A axon scanner (Molecular Devices U.K.) using autoPMT and the appropriate GAL (GenePix Array List) file. The image files were imported into Agilent's Feature extraction software to generate the raw data with signal intensities. Foreground log2(intensities) were normalized by quantile normalization [22] . For each gene, mean normalized intensities were compared between follicle stages (ED, LD, and PO) within each cell type (GC and TC) by ANOVA followed by t-tests using a modification of the Limma package [23] and Benjamini & Hochberg adjustment (FDRmax , 0.05).
Raw microarray data are available online at http://www.ncbi.nlm.nih.gov/ geo/ with GEO accession number GSE52109.
qPCR Analyses
Total RNA (100 ng) was reverse transcribed using SuperScript III (Life Technologies) and random primers in the presence of RNase inhibitor (Promega), as per manufacturer's instructions. SYBR green qPCR was performed with the SensiMix kit (Bioline) on a Stratagene MX3000P. All qPCR reactions were run in duplicate and included RT-negative and notemplate controls. The qPCR reactions involved a denaturation step for 10 min at 958C followed by 40 cycles of product amplification (each involving 15 sec at 958C, 30 sec at 608C, and 1 min at 728C) and a melting curve. The primers used were designed to span two different exons within the corresponding target genomic sequence (Supplemental Table S1 ; Supplemental Data are available online at www.biolreprod.org). The abundance of each target mRNA was calculated with Mx3000P PCR analysis software relative to a standard curve run at the same time and constructed from GC and TC pools. We used 18S RNA as internal control in all cases. The qPCR data were tested for normality using the Kolmogorov-Smirnoff test (P , 0.01) and log transformed if necessary before one-way ANOVA (general linear model procedure) followed by Tukey pairwise comparison tests, or unpaired t-tests were used to determine differences in gene expression between developmental stages.
Western Blotting
Ten micrograms of total protein from cell lysates or 2 ll of follicular fluid was diluted in Laemmli buffer containing SDS and 2-betamercaptoethanol, boiled at 958C for 3 min, and loaded onto 8%-16% polyacrylamide SDS gels. After electrophoresis, gels were transferred to nitrocellulose membranes overnight at 48C, after which these were washed with TBS (10 mM Tris, DONADEU ET AL.
150 mM NaCl, pH 7.4) containing 0.1% (v/v) Tween-20 (TBS-T) and incubated 1 h in blocking solution (5% [w/v] nonfat dry milk in TBS-T) and then overnight with anti-ITGA5 (1:250; a5-47; [24] ), anti-DAG (1:500; GTX105038; Genetex), anti-ENO1 (1:300; Sc-15343; Santa Cruz Biotechnology), anti-ITGB1 (1:250; [25] ), or anti-INHBB (1:200; kindly provided by W.W. Vale Jr, Salk Institute, La Jolla, CA), all diluted in blocking solution. The membranes were then sequentially washed with TBS-T, incubated for 1 h in blocking solution, incubated for 1 h with peroxidase-conjugated goat anti-rabbit IgG (Sigma) diluted 1:5000 in blocking solution, and finally washed with TBS-T. Peroxidase activity was detected with the ECL Select Western Blotting Detection Reagent (GE Healthcare) in a BIS 303 PC Bio-Imaging System using Image Quant software (GE Healthcare). Band intensity data were analyzed, after log transformation when necessary (Kolmogorov-Smirnoff test, P , 0.01), using the general linear model procedure by one-way ANOVA followed by Tukey pairwise comparison tests.
Immunohistochemistry
Pieces of follicular wall fixed in Bouin buffer and kept in ethanol were dehydrated and embedded in paraffin wax. Sections (5 lm) were cut, floated onto Superfrost Plus slides (J1800 AMNZ; Thermo Scientific), dried at 508C overnight, and then dewaxed and rehydrated. Antigen retrieval was carried out by microwaving in 0.01 M citrate buffer, pH 6.0, for 6 min. Endogenous peroxidase activity was blocked by incubating sections in 3% (v/v) hydrogen peroxide in methanol for 30 min. Sections were blocked using 20% normal goat serum, 5% bovine serum albumin in TBS for 30 min, then incubated overnight at 48C with rabbit anti-ovine a-gonadotropin subunit (ASMR20 91189, produced by A.S. McNeilly) diluted 1:100 in blocking buffer. Slides were then incubated with biotinylated goat anti-rabbit IgG (Dako U.K. Ltd.) diluted 1:500 for 30 min, then with streptavidin/HRP conjugate (Dako U.K. Ltd) diluted 1:1000 for 30 min. Antibody binding was visualized by incubation with 3,3 0 diaminobenzidine tetrahydrochloride (Dako U.K. Ltd). Sections were counterstained with hematoxylin, dehydrated, and then coverslip mounted using Pertex mounting medium (Cellpath Ltd.). Images were photographed using a Nikon microscope.
Gene Ontology Analysis
Human orthologs of equine transcripts differentially expressed in GCs or TCs between follicular stages were obtained using the online BioMart tool from Ensembl (http://www.ensembl.org/index.html). Human orthologs were identified for 77%, 65%, and 78% of all transcripts differentially expressed during the ED-LD transition in GCs, the LD-PO transition in GCs, and the LD-PO transition in TCs, respectively. These were then analyzed using Ingenuity Pathway Analysis (IPA; Ingenuity Systems; http://www.ingenuity.com) to identify, from the IPA Knowledge Base, significantly overrepresented biological pathways using right-tailed Fisher exact tests (P , 0.05). Additional gene ontology information was sourced from Entrez Gene (http://www.ncbi. nlm.nih.gov/gene/), Ensembl (http://www.ensembl.org/index.html) and SCCPIR Ovarian Kaleidoscope (http://ovary.stanford.edu/) databases.
RESULTS
Follicle development was monitored daily by ultrasound to ensure that only morphologically normal, growing dominant follicles were collected. Mean (6SEM) follicle diameters at ovarian collection were 24.3 6 0.5, 33.8 6 0.6, and 39.6 6 0.5 mm for the ED, LD, and PO groups, respectively (n ¼ 5 mares/group). Follicular-fluid levels of estradiol were 1.2 6 0.3, 1.8 6 0.3, and 1.6 6 0.1 lg/ml and progesterone levels were 4.4 6 1.0, 8.2 6 1.6 and 145.7 6 100.6 ng/ml in each of the three groups, respectively. These profiles are consistent with those reported for equivalent developmental stages of dominant follicles in previous studies [6, 26] .
Differential Gene Expression Profiles in GCs Across Follicular Stages
A total of 546 and 2419 unique transcripts were differentially expressed (!2-fold; Benjamini & Hochberg FDR, P , 0.05) in GCs during the transitions ED-LD and LD-PO, respectively ( Fig. 1 and Supplemental Table S2 ). Changes in expression of selected genes during each developmental transition were validated by qPCR (Fig. 2, A and B , and Supplemental Fig. S1 ) and, whenever antibodies were available, by Western blotting (Fig. 3) ; in all cases, changes in levels of both transcript and protein were in agreement with results of microarray analyses.
The top 15 up-regulated and down-regulated protein-coding transcripts in GCs during each developmental transition are shown in Tables 1 and 2 . PTX3, a gene involved in immune and inflammatory responses and with an essential role in female fertility [27] , was the top up-regulated transcript (54-fold) in GCs during ED-LD (Table 1) , followed by other mediators of immunity and inflammation (NTS, SPP1, S100A12, OLR1) and several transcripts putatively involved with the extracellular matrix (ECM) and/or tissue remodeling (HAS2, PCOLCE2, PLAT, TNFRSF12A, EFEMP1) and neuronal development (NPTX2, CHN1, SERPINI1). As for down-regulated transcripts, HSD17B1 was top, followed by CPS1, a mitochondrial enzyme involved in the removal of excess ammonia that is primarily expressed in liver and intestine but also in GCs [28] . Other down-regulated transcripts included several core regulators of cell division (ASPM, TPX2, CDC20, BUB1, BUB1B, TKK).
During the LD-PO transition (Table 2) , two putative orthologs of the human secretoglobulins, SCGB2A1 and SCGB2A2, were among the most up-regulated transcripts in GCs, followed by several inflammation and tissue-remodeling genes (PLAU, FGG, EDN2, PTGS2, NTS) already known to be involved in ovulation [10, 18, 29] as well as transcripts involved in cell survival and differentiation (BDNF, NELL2, DKK1, NIM1-like), lipid metabolism (AGPAT4, APOE), and immunity (DEFB1). As during ED-LD, most down-regulated transcripts during LD-PO in GCs corresponded to genes involved in cell division (SPC25, TOP2A, UBE2C, HFM1, ASPM, NDC80, KIF11, CDC20), in addition to HSD17B1. Other down-regulated transcripts were THSD1, a type 1 thrombospondin domain-containing protein with unknown function; PTPRZ1, which is involved in neural development; and the heparan-synthesizing enzyme, HS3ST1.
Comparing gene expression profiles between developmental transitions in GCs revealed that as many as 42% of transcripts differentially expressed during ED-LD showed the same trend (i.e., up-or down-regulation) during LD-PO; of these, 46 transcripts were up-regulated during the two transitions and 186 were down-regulated ( Fig. 1 and Supplemental Table S3 ). Among the top co-up-regulated transcripts were NTS and others corresponding to genes involved in tissue remodeling and growth (EFEMP1, PRKX, MMP1, EPS8, COL4A1) and protection against oxidative damage (SOD2, GPX3). A majority of transcripts down-regulated in GCs during both ED-LD and LD-PO corresponded to genes associated with the cell cycle (Supplemental Table S3 ).
Differential Gene Expression Profiles in TCs Across Follicular Stages
Compared to GCs, relatively low numbers of transcripts were differentially expressed in TCs during each of the ED-LD and LD-PO transitions (Fig. 1) , consistent with results in cattle [6, 30] . Out of a total of five differentially expressed transcripts in TCs during ED-LD (Supplemental Table S2 ), four corresponded to putative protein-coding genes, namely, two histone clusters (a HIST1H2AD ortholog and HIST2H2AA3, both up-regulated in LD) and ANKDD1B and PTCH1 (both down-regulated in LD).
A total of 422 and 160 unique transcripts were respectively up-regulated and down-regulated in TCs during LD-PO (Fig. 1 THE DOMINANT FOLLICLE TRANSCRIPTOME and Supplemental Table S2 ). As was the case for GCs, results of microarray analyses were validated by qPCR to confirm the up-regulation or down-regulation of selected transcripts in TCs during LD-PO (Fig. 2C) . Among up-regulated transcripts (Table 3) , the opioid precursor, PENK, and the gonadotropin alpha subunit (CG) were top. Expression of CG, a gene putatively expressed only in pituitary and placenta, in equine dominant follicles could not be quantified at the protein level by Western blotting using available antibodies; however, the presence of CG protein in theca but also granulosa was confirmed by immunohistochemistry (Fig. 4) . In addition to PENK and CG, different regulators of cell proliferation and differentiation were up-regulated in TCs during LD-PO; among these, some have already been described in relation to follicular differentiation (NR4A2, EREG; [31, 32] ) but others, including the pituitary cell differentiation-associated gene TBX19, the putative BMP inhibitor CHRDL2, the ubiquitous retinalprocessing enzyme ALDH1A3, and the negative epidermal growth factor (EGF) regulator involved in skin morphogenesis, ERRFI1, have not been associated previously with follicle development. Other highly up-regulated transcripts are putatively involved in cell adhesion and the ECM (DSCAM, ADAMTS4) and in inflammation and immunity (TAC1, DARC, C3-like).
Top down-regulated transcripts in TCs during LD-PO included GLI1 and PTCH1, two components of sonic hedgehog signaling known to be involved in TC function [33] ; several genes putatively involved in different tissues in regulation of cell proliferation and differentiation (MYCN, FIGN, MTA3, RUNX1T1) and cell protection against lipid oxidation or xenobiotic/carcinogen insult (PON1, GSTO2); the gene involved in melanosome transport, MLPH; the phosphoserine-metabolizing enzyme, PSAT1; and other genes for which function has not been extensively characterized.
Comparing expression profiles between GCs and TCs during LD-PO showed that only 88 transcripts (corresponding to 3.6% and 15% of all differentially expressed transcripts in GCs and TCs, respectively) were simultaneously up-regulated (62 transcripts) or down-regulated (26 transcripts) in the two cell types (Fig. 1 and Supplemental Table S3 ). Another eight transcripts showed different expression trends between GCs and TCs (Supplemental Table S3 ). The G-protein signaling regulator, RGS2, was the top co-up-regulated protein-coding transcript, followed by many others mapping to genes involved in immunity (SH2D1A, NFIL3, TLR4, CMRF35-like molecule 6, CXCL3, CXCL2, BD128, TOX, CD68, CXCL1, FCER1G), cell proliferation (DUSP1, PTP4A1, MYCN), differentiation (NR4A3, RCAN3, TAF3, NR4A1, POU2F2, NKX2-1, PTPRD, ACVR1C), and adhesion/migration (FUZ, SSH2, ITGB6) (Supplemental Table S3 ). Co-down-regulated transcripts coding for genes with known function included transcriptional regulators (RUNX1T1, ZFN618, RCOR3, ZFN624, ZFN827, NR3C1) and genes involved in cell survival (FAIM), cell polarity (DAAM1), and DNA repair (MSH6).
Ontology Analysis of Differentially Expressed Gene Sets in GCs and TCs
Differentially expressed transcript sets were analyzed using IPA to identify biological pathways overrepresented during each follicular stage transition in GCs and TCs. During the ED-LD transition in GCs there was a highly significant association between down-regulated transcripts and several pathways involved in cell division, including DNA replication, mitosis, cell cycle checkpoint, DNA repair, and apoptosis ( Fig. 5A and Supplemental Table S4 ). Similarly, during the LD-PO transition a large set of down-regulated transcripts in GCs was highly enriched with genes involved in cell division, whereas other sets of up-or down-regulated transcripts mapped to pathways that could be functionally grouped into cell-cell communication and cell adhesion, anti-oxidation/detoxification, immunity and inflammation, carbohydrate and amino acid metabolism, cholesterol biosynthesis, and others, including endothelin-1 signaling (Fig. 5B and Supplemental Table S4 ).
Finally, during the LD-PO transition in TCs most upregulated transcripts were associated with immunity and inflammation pathways, in addition to pathways related to GPCR/cAMP signaling, cell death, and cell proliferation and differentiation ( Fig. 5C and Supplemental Table S4 ); other differentially expressed transcript sets mapped to several amino acid and lipid metabolism pathways.
DISCUSSION
To our knowledge, this study reports the first transcriptomewide analysis of follicle development in the horse. A series of earlier studies by Sirois and associates using Southern blotting and semiquantitative PCR [18, [34] [35] [36] [37] [38] [39] [40] [41] provided detailed expression profiles for a limited number of genes during the equine PO period. Gene expression data in relation to the long period of dominant follicle growth that precedes the PO period are particularly limited in the horse [26, 42] . Transcriptome analyses of dominant follicles in cattle, another monovular species, have been reported, although considerably more emphasis was placed on the PO stage than on the phase of dominant follicle growth, particularly as it relates to the separate granulosa and theca components [43, 44] . Considering the unique features of equine follicle development, including close similarities in follicular patterns between horses and humans [12, 45] , the comprehensive, spatiotemporal gene expression profiles reported in the present study should provide important clues on the molecular mechanisms regulating the growth and maturation of dominant follicles in the monovular ovary, particularly as several genes were identified that have not previously been associated with folliculogenesis.
The most salient feature during the development of dominant follicles was the down-regulation of GC transcripts involved in cell division. Although it is well accepted that the ovulatory LH surge triggers GC cycle arrest [46] , a decrease in the levels of transcripts associated with all of DNA replication, mitosis, cell cycle checkpoint, and DNA repair earlier during the growth of the dominant follicle (Fig. 5A) has not been previously documented. These novel findings confirm earlier observations in several species that both the rate of GC proliferation [47, 48] and the expression of proliferationassociated genes [8, 49] decrease during the final stages of antral follicle growth. Further, studies in ruminants have shown that the dominant follicle switches its dependence for growth from follicle-stimulating hormone (FSH) to LH [50] and that
FIG. 2.
Results of microarray data validation using qPCR. Selected transcripts for which expression had been found to be up-regulated (left panels) or down-regulated (right panels) during A) the ED-LD transition in GCs, B) the LD-PO transition in GCs, and C) the LD-PO transition in TCs were analyzed (n ¼ 5 follicles/group). Expression levels were calculated as described in Materials and Methods, and mean values 6 SEM are shown. Significant differences identified by t-tests are shown: *P 0.05 and **P 0.01.
THE DOMINANT FOLLICLE TRANSCRIPTOME this is associated with a reduction in the expression of FSHresponsive genes involved in cell proliferation and apoptosis [43] . In the horse, the relatively high circulating levels of LH associated with the development of dominant follicles would be expected to contribute significantly to a reduction in GC proliferation, presumably a prerequisite for adequate follicle maturation in preparation for ovulation.
Changes in gene expression during the LD-PO transition were in general consistent with the limited literature available on equine PO follicles [18, 35-37, 39, 40] . Many of the top upregulated transcripts in GCs during the LD-PO transition (PLAU, EDN2, PTGS2, BDNF, NTS) are known to play important roles in immunity, ECM/tissue remodeling, and cell survival during ovulation [10, 18, 29, 51, 52] , whereas others, such as the antimicrobial DEFB1, the WNT inhibitor DKK1, the tissue development-associated gene NELL2, and the lipidsynthesizing enzyme AGPAT4, are reportedly expressed in these cells [53, 54] , but their involvement in follicle development has not been described. Among such genes were also two putative orthologs of the members of the human secretoglobulin 2A family, SCGB2A1 and SCGB2A2. These are small dimeric proteins, specific of mammals, found at high levels in many body secretions [55] . SCGB2A1 and SCGB2A2 have poorly conserved sequences and are overexpressed in several gynecological cancers. Moreover, their tissue expression is under steroid regulation [56, 57] . Although the actual biological functions of SCGBs are in general poorly understood, there is evidence of their anti-inflammatory and immunomodulatory effects [55] ; in light of this, the current results suggest potentially important roles of SCGB2A family members during ovulation, a proposition that needs to be further investigated.
As during the LD-PO transition, during ED-LD several transcripts involved in immunity and tissue growth/ remodeling   FIG. 3 . Results of validation of microarray data by both qPCR and Western blotting. Selected genes for which expression in GCs had been found to be up-regulated (ITGA5) or down-regulated (DAG1) during ED-LD, or to be up-regulated (ENO1, ITGB1) or down-regulated (INHBB) during the LD-PO transition were analyzed (n ¼ 5 follicles/group) in GCs by qPCR (upper row) and Western blotting (middle row) and in follicular fluid by Western blotting (lower row). Expression levels were calculated in each case as described in Materials and Methods, and mean values 6 SEM are shown. Representative immunoblots are shown for each protein analyzed, with numbers to the left of each blot representing molecular mass (kDa) from a protein standard run simultaneously. For INHBB, a single 50-kDa band was identified in GCs and three different bands (50, 35 , and 12 kDa) in follicular fluid. Two different bands (120 and 140 kDa) were identified for ITGB1 that were combined for quantification of protein levels. ITGA5, ENO1, and ITGB1 were not detected in follicular fluid. There was a significant main effect of follicle group (P , 0.05) on transcript levels of ITGA5, DAG1, and INHBB and on protein levels of ITGA5, ENO1, ITGB1, and INHBB1, whereas an effect on DAG1 protein levels approached significance (P ¼ 0.065). A main effect of follicle group on follicular fluid levels of 35 kDa INHBB was also significant (P ¼ 0.04). Whenever significant differences between follicle groups were detected by Tukey tests (P 0.05) these are shown with different superscripts (a ,b, c) .
were significantly up-regulated in GCs (Table 1) . Innate immunity plays a role in the dominant follicle not only during ovulation but also earlier during growth [58] [59] [60] [61] ; some of the top up-regulated immune genes in this study, such as the cytokine SPP1, have already been reported to increase during the growth of bovine follicles [30] , whereas others, such as the calcium-binding protein S100A12, have not been associated previously with folliculogenesis. In other species, expression of the hyaluronan synthase HAS2 increases in cumulus cells before ovulation and, together with the immune gene PTX3, HAS2 plays a key role in cumulus-oocyte-complex matrix expansion [27] . In the mare, in addition to the cumulus, the mural GC layer expands before ovulation, a phenomenon not observed in other species, and this is associated with an increase in mural HAS2 levels [41, 62] . Consistent with these findings, HAS2 levels increased 3-fold in GCs of PO follicles relative to LD follicles (Fig. 2B) . However, an increase in HAS2 expression during the growth of the dominant follicle (ED-LD transition; Fig. 2A) has not been reported earlier in any species. Hyaluronan production by GCs is thought to significantly contribute to the buildup of follicular fluid during antral expansion [63] ; given the significant and rapid increase in the antral volume of equine dominant follicles (over 13 ml as follicles grow from 24 to 34 mm in less than 4 days), the large THE DOMINANT FOLLICLE TRANSCRIPTOME increase in HAS2 expression during ED-LD in this study is not surprising. Whether such increase also occurs during follicle growth in other species remains to be determined; nonetheless, the present results indicate a role of HAS2, and presumably PTX3, in facilitating the growth of the equine dominant follicle before it reaches the PO stage. Compared to GCs, the TC transcriptome has to this date received limited attention. In the present study, overall gene expression profiles in equine theca interna were clearly distinct from those in GCs. A large proportion of up-regulated transcripts in theca during LD-PO uniquely mapped to numerous immune and inflammatory pathways, particularly pathways involved in leukocyte migration/adhesion and activation (Fig. 5C) , indicative of an active recruitment of immune cells through the thecal vasculature. A massive infiltration of leukocytes, primarily eosinophils, into the thecal layer has been reported just before ovulation in mares, with hyperemia, edema, and hemorrhage all occurring within 9-12 h before follicular rupture [62] . Putatively involved in inflammatory responses is also the opioid precursor, PENK, which interestingly was the most up-regulated transcript in TCs during LD-PO (Table 3) . A previous study reported an increase in the expression of penk in murine cumulus cells during ovulation [52] . Moreover, porcine GCs and oocytes express the putative enkephaline receptor OPRD1 [64] . In addition to its best-known role as a mediator of pain responses, PENK may also regulate follicular steroidogenesis and oocyte maturation [65, 66] . A functionally related gene, the vasoactive neuropeptide tachykinin 1, was also highly up-regulated in equine theca (Table 3) . TAC1 is reportedly expressed in stromal cells as well as steroidogenic cells within the ovary [67] . It is an injury-inducible factor that orchestrates cellular responses involved in wound healing, including pain reception [68] . In the context of the ovary, TAC1 has shown to stimulate LHinduced progesterone secretion and to contribute to luteal development [67, 69] , findings that are consistent with the increased levels of this transcript in PO follicles in this study. Another highly expressed transcript in TCs was the T-box 19, a gene originally identified in pituitary cells but also reported to be expressed in murine and human ovarian follicles [52, 53] ; DONADEU ET AL. On the x-axis is the percentage or ratio of genes in a given pathway that are present within each data set. Ratios are always positive; negative ratio values for down-regulated genes are given only for illustrative purposes. Full results using IPA are provided in Supplemental Table S4 .
THE DOMINANT FOLLICLE TRANSCRIPTOME intriguingly, one of the functions of TBX19 is transcriptional activation of the opioid precursor, POMC. Taken together, the present results in mares indicate a previously unreported involvement of endogenous pain control mechanisms in the ovulatory process. Two unexpected findings of the present study were the ready detection of CG transcript in follicular cells (at levels on average about 10-fold lower than in equine pituitary; data not shown) and the marked increase in CG expression during LD-PO, as it has been generally accepted that gonadotropin subunits are primarily if not exclusively expressed in pituitary and placenta. To investigate whether CG transcript was also present in the follicles of another monovular species, the cow, we performed qPCR analysis of healthy PO-size follicles collected in a previous study [70, 71] but failed to obtain any detectable transcript amplification (data not shown). Similarly, earlier efforts failed to detect expression of gonadotropin alpha subunit in ovine ovaries (A.S. McNeilly, unpublished results). In contrast, consistent with the present results in horses, the gonadotropin alpha subunit has reportedly been detected by microarray analyses of human follicular cells [53] , and others have reported the presence of gonadotropin alpha and FSH beta subunits in ovarian luteal and interstitial cells of normal adult mice [72] . In the present study, we also sought to determine the presence of gonadotropin beta subunits in equine follicular cells using qPCR. Although we were unable to detect FSHB, LHB transcript was readily amplified in both GCs and TCs, being present at levels about 10-and 30-fold lower, respectively, than those in equine pituitary (data not shown); however, unlike CG transcript levels, LHB did not increase across the follicle stages examined. Taken together, these novel findings suggest a potential and hitherto unreported role of the gonadotropin alpha subunit in regulation of the final stages of follicle development. What this role may be and whether or not it is unique to the mare should be the focus of future investigation.
Several pathways involved in cell proliferation/survival and differentiation, including angiogenesis (FGF, HIF1a signaling), were overrepresented among genes up-regulated in theca during LD-PO (Fig. 5C ), a reflection of profound follicular wall remodeling during the PO period. Two highly upregulated transcripts in TCs were NR4A2, a transcriptional repressor of steroidogenic genes during ovulation [31] , and the EGF-like factor, EREG, which has a key role in mediating LHinduced oocyte maturation and cumulus expansion [32] . These two genes are reportedly expressed transiently in both GCs and TCs [40, 73] but their involvement during ovulation has been described only in relation to granulosa. In an earlier study, levels of EREG transcript increased in both GCs and TCs, although not simultaneously, in response to an ovulatory dose of hCG in PO mares [40] . Given the temporal nature of the changes in the expression of many genes during the periovulatory period [36, 40] , the fact that PO follicles were analyzed at a single time point after CEG administration in the present study may have prevented identifying a rise in transcript levels of EREG, and perhaps NR4A2, in GCs in addition to TCs. Nevertheless, the present results point to a potential role of these two key factors in TCs during ovulation.
Compared to GCs, only a small proportion of transcripts were down-regulated in TCs during the PO period. Although the putative follicular roles of many of these transcripts are not known, interestingly, among the most down-regulated were the transcription factor, GLI1, and its upstream activator, the hedgehog receptor, PCHT1 (Table 3) . Results in rodents and cattle has shown that the hedgehog genes, IHH and DHH, are produced in GCs and putatively activate thecal PTCH1 and GLI1 to stimulate theca proliferation and androgen biosynthesis [33, 74, 75] . Not surprisingly, ihh, dhh, pitch1, and gli1 all decrease in expression before ovulation in mice [74] . Consistent with that finding, in addition to a decrease in GLI1 and PTCH1 in TCs, the expression of IHH decreased 4-fold in GCs during LD-PO in the present study (Fig. 2B) . Thus, the present results are important as they provide support for a conserved role of hedgehog signaling as a key factor in the crosstalk between GCs and TCs during follicle differentiation.
In summary, microarray analyses of equine dominant follicles followed by selective qPCR and immune-mediated protein detection identified distinct gene expression profiles and cellular pathways associated with both developmental stage, i.e., follicle growth (ED-LD) versus PO maturation (LD-PO), and follicular cell type, i.e., GC versus TC. The most prominent features were a decrease in the expression of genes associated with GC division during both follicle growth and PO maturation and the up-regulation of genes associated with immunity and inflammation during the PO period in GCs and, particularly, TCs. In conclusion, this study provides novel and comprehensive information on gene expression, both spatially and temporally, associated with the development of dominant follicles in the monovular ovary, and identifies novel genes putatively involved in follicle development.
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